[Congressional Record (Bound Edition), Volume 151 (2005), Part 6]
[Senate]
[Page 7577]
[From the U.S. Government Publishing Office, www.gpo.gov]




              CORRECTING THE ANABOLIC STEROID CONTROL ACT

  Mr. INHOFE. Mr. President, I ask unanimous consent that the Senate 
proceed to the immediate consideration of S. 893, introduced earlier 
today.
  The PRESIDENT pro tempore. The clerk will report the bill by title.
  The assistant legislative clerk read as follows:

       A bill (S. 893) to make technical corrections to the 
     Anabolic Steroid Control Act of 2004.

  There being no objection, the Senate proceeded to consider the bill.
  Mr. INHOFE. I ask unanimous consent the bill be read a third time and 
passed, the motion to reconsider be laid on the table, and any 
statements relating thereto be printed in the Record, without 
intervening action or debate.
  The PRESIDENT pro tempore. Without objection, it is so ordered.
  The bill (S. 893) was read the third time and passed, as follows:

                                 S. 893

       Be it enacted by the Senate and House of Representatives of 
     the United States of America in Congress assembled,

     SECTION 1. TECHNICAL CORRECTIONS.

       Section 102(41)(A) of the Controlled Substances Act (21 
     U.S.C. 802(41)(A)), as amended by the Anabolic Steroid 
     Control Act of 2004 (Public law 108-358), is amended by--
       (1) striking clause (xvii) and inserting the following:
       ``(xvii) 13b-ethyl-17b-hydroxygon-4-en-3-one;''; and
       (2) striking clause (xliv) and inserting the following:
       ``(xliv) stanozolol (17a-methyl-17b-hydroxy-[5a]-androst-2-
     eno[3,2-c]-pyrazole);''.

                          ____________________